Compound Income
  • Blog
  • Scores
    • Scores Presentation
  • Portfolio
    • Table of Returns
  • Resources
    • Check list
  • About
  • Contact



Death of Democracy & Healthy Cost Savings.

14/7/2015

0 Comments

 
So in the usual one minute to midnight fashion or maybe 6am in this case, the EU and Greece came up with a new fudged proposal to bail out the Greek economy for another three years - maybe. I find it sad that in the home of democracy they went though the charade of giving the people a vote on whether to accept or reject further austerity then turn around and sign up for pretty much what had been rejected while extracting little or nothing in the way of concessions or badly needed debt relief. It seems unlikely to me that further spending cuts and tax rises and staying in the Euro is going to do much for the plight of the sickly Greek economy.

Consequently it remains to be seen if they will get it through parliament or not or if there will be a popular back lash against this apparent injustice. I also find it strange that the EU leaders tried to manipulate the vote by saying a No would mean an exit from the Euro, while The European commission president, Jean-Claude Juncker said pretty much the same thing.
Meanwhile a week on Junker says "there will be no Grexit, satisfied with deal" with the inconvenient No vote apparently meaning nothing and promptly being forgotten about. This carries on the pattern of No votes in referenda being generally ignored as EU leaders carry on with their grand plan for ever closer union regardless and do their utmost to keep the Euro from falling apart. As a result the poor Greeks are losing much of their sovereignty to the EU which is the ultimate goal of ever closer union at the end of the day. Oh well plus ça change as they say in France, but as investors I guess we should just be happy that the uncertainty is over for now (assuming it is approved by the Greek parliament) and that markets can maybe focus on something else for now until the next inevitable Greek crisis blows up again a few years down the line.

Talking of which we have had a trading update from EMIS Group (EMIS) the £600m Aim listed UK leader in connected healthcare software and services which is helping another over spending outfit, the NHS in England, to achieve cost savings. In their in line update today they flagged that the NHS in England has identified the need to create £22bn in efficiency savings to fill a £30bn gap between likely demand and funding by 2020, Tim Kelsey, National Director for Patients and Information at NHS England, has announced that the use of digital technology can create savings of £8.3bn to £13.7bn a year by then. Emis therefore see themselves as being well placed to help with delivering some of this given their strong market positions in some key areas such as GP surgeries, Primary & Community Care, Community Pharmacies and Secondary and Specialist Care software.

Longer term readers may remember that this is one I suggested looking into when it was down around 600p per share in 2014. Since then it has done well and been re-rated onto a fairly full looking rating of around 20x with a yield of just over 2% but with 20%+ earnings growth forecast for the current year.

As I have explained in the past with posts on sell discipline here and here which outlined why I tend to use those kind of metrics (20x & 2%) as a trigger for re-considering a stock as don't tend to buy stocks on that kind of rating and above.
Thus this one is one I have been toying with the idea of selling, but for now I have continued to run it as it continues to be a good quality company which is continuing to perform well and which has seen upgrades to earnings this year. While looking ahead, given the statement today and the separate announcement of another small (£3m) earnings enhancing acquisition, this should help to underpin and possibly lead to further upgrades to earnings. On this basis I'm still just about inclined to run with it given the continued positive trading, but accept that a further upwards re-rating seems unlikely. However if I do find something offering similar quality and growth but on a more reasonable rating then I may rotate into that, so a hold / look to sell up here rather than a buy I would say.

Picture
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    RSS Feed

    Google+

    Archives

    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    June 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014

    Categories

    All
    32Red
    Aberdeen Am
    Admin
    A G Barr
    Alliance Pharma
    Alternative Telecoms
    AMEC
    Amino Technologies
    Amlin
    Anglo Pacific
    Asset Allocation
    Auto Trader Group
    BA Systems
    BATS
    Behavioural Finance
    Bellway
    Berendsen
    BHP Billiton
    Bloomsbury Publishing
    Bodycote
    Books
    Bovis Homes
    BREXIT
    Britvic
    Catlin-group
    Central Asia Metals
    Centrica
    Character Group
    Churchill China
    Cineworld
    City Of London Investment Group
    Clarkson
    Commercial Property
    Compound
    Computacenter
    Connect Group
    Croda
    Currencies
    Demographics
    Diageo
    Diploma
    Directors Dealings
    Dividends
    Easyjet
    Economics
    Emerging Markets
    Emis
    Empiric Student Property
    Etfs
    Fairpoint
    Ferguson
    Ferrexpo
    Finsbury Foods
    Food Retailers
    Forterra
    Games Workshop
    Gateley
    Go Compare
    Goid
    Greene King
    GSK
    Hargreaves Services
    Hays
    Headlam
    Hedge Funds
    Hill & Smith
    House Builders
    Howden
    HSBC
    IG Group
    Imperial Tobacco
    Indivor
    Inflation
    Insurance
    Intermediate Capital
    Interserve
    Investec
    Investment Trusts
    It
    ITV
    James Halstead
    Jarvis Investment Management
    JLT
    Jupiter Fund Management
    KCOM
    Kingfisher
    Legal & General
    Lloyds Bank
    Maintel
    Man Group
    Market Timing Indicator
    Market Valuation
    Marston's
    Matchtec
    Media
    Merlin Entertainment
    Micro Focus
    Mining
    Mitie
    Miton Group
    Moenysupermarket
    Mondi
    Moneysupermaket.com
    Music
    National Grid
    N.Brown
    News
    Next
    Nichols
    Norcros
    Oil
    Page Group
    Paypoint
    Pennon
    Persimmon
    Personal Finance
    Pharmaceuticals
    Phoenix Group
    Photo Me
    Photo-Me
    Plus500
    Podcasts
    Polar Capital
    Politics
    Portfolio
    Portmeirion
    Provident Financial
    PZC
    Qinetiq
    Ramsdens Holdings
    Rank Group
    Reckitt Benckiser
    Renewable Energy
    Renew Holdings
    Renishaw
    Research Papers
    Restaurant Group
    Retailers
    RIO
    RM Group
    Rolls Royce
    RPC
    RPS
    Safestore
    Sage
    Sainsburys
    Savills
    Schroders
    Scores
    SCS Group
    Sell Discipline
    Shareholder Yield
    Share Picks
    Short Interest
    Somero
    Spectris
    Sprue Aegis
    SSE
    Stock Spirits
    S & U Plc
    TalkTalk
    Taptica
    Tax
    Technology
    Telecoms
    Tobacco
    Trading Ideas
    TSB
    TUI
    UK Market Update
    Unilever
    Utilitywise
    Value
    Victrex
    Vodafone
    VP.
    Water Utilities
    Watkins Jones
    WH Smiths
    William Hill
    Wynstay
    XL Media
    XP Power
    Yield
    Zytronic

    googleda4a17cac6d02bb9.html
    File Size: 0 kb
    File Type: html
    Download File

Powered by Create your own unique website with customizable templates.
  • Blog
  • Scores
    • Scores Presentation
  • Portfolio
    • Table of Returns
  • Resources
    • Check list
  • About
  • Contact